A heterologous prime-boost regime using DNA and recombinant vaccinia virus expressing the Leishmania infantum P36/LACK antigen protects BALB/c mice from cutaneous leishmaniasis.

Gonzalo, Rosa M; del Real, Gustavo; Rodriguez, Juan R; Rodriguez, Dolores; Heljasvaara, Ritva; Lucas, Pilar; Larraga, Vicente; Esteban, Mariano

Gonzalo, Rosa M; del Real, Gustavo; Rodriguez, Juan R; Rodriguez, Dolores; Heljasvaara, Ritva; Lucas, Pilar; Larraga, Vicente; Esteban, Mariano.

Affiliation

Gonzalo RM; Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología, Universidad Autónoma Campus de Cantoblanco, CSIC, 28049, Madrid, Spain.

Vaccine ; 20(7-8): 1226-31, 2002 Jan 15.

Article in En | MEDLINE | ID: mdl-11803085

Subject(s)

Crystallins/immunology; Leishmania infantum/immunology; Leishmaniasis, Cutaneous/prevention & control; NAD(P)H Dehydrogenase (Quinone)/immunology; Protozoan Vaccines/immunology; Vaccines, DNA/immunology; Vaccines, Synthetic/immunology; Animals; Crystallins/genetics; Female; Immunization; Interferon-gamma/biosynthesis; Interleukin-10/biosynthesis; Mice; Mice, Inbred BALB C; NAD(P)H Dehydrogenase (Quinone)/genetics; Vaccinia/genetics; zeta-Crystallins

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Vaccines, Synthetic / Protozoan Vaccines / NAD(P)H Dehydrogenase (Quinone) / Leishmaniasis, Cutaneous / Leishmania infantum / Vaccines, DNA / Crystallins Type of study: Prognostic_studies Limits: Animals Language: En Journal: Vaccine Year: 2002 Document type: Article Affiliation country: Spain Country of publication: Netherlands

Search on Google

Add to My VHL

XML

PubMed Links